Received Nov 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | — |
elevated troponin; This spontaneous case was reported by a consumer and describes the occurrence of TROPONIN INCREASED (elevated troponin) in a patient of an unknown age and gender who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form. On an unknown date, the patient experienced TROPONIN INCREASED (elevated troponin). At the time of the report, TROPONIN INCREASED (elevated troponin) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Troponin: elevated. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Unknown) was unknown. This case contains information for the 1st of 3 patients described by the reporter. Concomitant medications were not reported. It was reported that the data came from a randomized, placebo-controlled phase 4 trial in which researchers measured troponin levels a marker of heart injury. It was reported that after vaccination only three participants showed elevated troponin after receiving the shot, and Pfeiffer was dismissed those as being caused by "physical activity." Treatment information was not reported. This case was linked to US-MODERNATX, INC.-MOD-2025-790703, US-MODERNATX, INC.-MOD-2025-790704 (E2B Linked Report).; Reporter's Comments: The benefit-risk relationship of the product is not affected by this report.; Sender's Comments: US-MODERNATX, INC.-MOD-2025-790703:different patient US-MODERNATX, INC.-MOD-2025-790704:different patient
Test Name: troponin; Result Unstructured Data: elevated